Presentation is loading. Please wait.

Presentation is loading. Please wait.

David valve-sparing aortic root replacement: Equivalent mid-term outcome for different valve types with or without connective tissue disorder  John-Peder.

Published byDarleen Evans Modified over 5 years ago

Similar presentations

Presentation on theme: "David valve-sparing aortic root replacement: Equivalent mid-term outcome for different valve types with or without connective tissue disorder  John-Peder."— Presentation transcript:

1 David valve-sparing aortic root replacement: Equivalent mid-term outcome for different valve types with or without connective tissue disorder  John-Peder Escobar Kvitting, MD, PhD, Fabian A. Kari, MD, Michael P. Fischbein, MD, PhD, David H. Liang, MD, PhD, Anne-Sophie Beraud, MD, Elizabeth H. Stephens, MD, PhD, R. Scott Mitchell, MD, D. Craig Miller, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 1, Pages e5 (January 2013) DOI: /j.jtcvs Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 A, Distribution of patients undergoing valve-sparing aortic root replacement according to type of aortic valve. B, Age distribution of patients with tricuspid (TAV) and bicuspid aortic valve (BAV). C, Distribution of patients (n, %) with a BAV according to Sievers’ classification. D, Distribution of arch replacement during study period according to valve type. The Journal of Thoracic and Cardiovascular Surgery  , e5DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 A, Kaplan-Meier survival curve for 233 patients undergoing valve-sparing aortic root replacement. B, Kaplan-Meier survival curve of 233 patients undergoing valve-sparing aortic root replacement compared with general US population matched for age, gender, and race. C, Kaplan-Meier survival curves comparing tricuspid (TAV) and bicuspid aortic valve (BAV) subsets. D, Kaplan-Meier survival curves comparing patients with confirmed diagnosis of Marfan syndrome or other connective tissue disorders (CTDs) compared with remainder of patients. Vertical bars represent ± 1 standard error. The Journal of Thoracic and Cardiovascular Surgery  , e5DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 A, Freedom from reoperation on aortic root after valve-sparing aortic root replacement. B, Freedom from reoperation on aortic root comparing tricuspid (TAV) and bicuspid aortic valve (BAV) subsets. C, Freedom from reoperation on aortic root after valve-sparing aortic root replacement comparing patients with confirmed Marfan syndrome or another connective tissue disorder (CTD) and remainder of patient cohort. Vertical bars represent ± 1 standard error. The Journal of Thoracic and Cardiovascular Surgery  , e5DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

5 Figure E1 A, Freedom from Stanford type B aortic dissection for all patients. B, Freedom from Stanford type B aortic dissection comparing patients with confirmed diagnosis of Marfan syndrome or other connective tissue disorder (CTD) with remainder of patients. C, Freedom from more than 2+ aortic regurgitation. Vertical bars represent ± 1 standard error. The Journal of Thoracic and Cardiovascular Surgery  , e5DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

6 Figure E2 A, Freedom from structural valve deterioration (SVD) after valve-sparing aortic root replacement. B, Freedom from SVD comparing tricuspid (TAV) and bicuspid aortic valve (BAV) subsets. C, Freedom from SVD comparing patients with confirmed diagnosis of Marfan syndrome or other connective tissue disorder (CTD) and remainder of patients. Vertical bars represent ± 1 standard error. The Journal of Thoracic and Cardiovascular Surgery  , e5DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

7 Figure E3 A, Freedom from structural valve deterioration comparing patients with 4+ aortic regurgitation (AR) preoperatively and remainder of patients. B, Freedom from reoperation on aortic root comparing patients with 4+ aortic regurgitation preoperatively and remainder of patients. Vertical bars represent ± 1 standard error. The Journal of Thoracic and Cardiovascular Surgery  , e5DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "David valve-sparing aortic root replacement: Equivalent mid-term outcome for different valve types with or without connective tissue disorder  John-Peder."

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Justin M. Schaffer, MD, Bharathi Lingala, PhD, D. Craig Miller, MD, Y

Justin M. Schaffer, MD, Bharathi Lingala, PhD, D. Craig Miller, MD, Y
Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R

Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R
Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.

Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.
Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E

Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E
Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H

Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H
Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,
Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D
Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.

Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.
Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis  Evaldas Girdauskas,

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis  Evaldas Girdauskas,
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.
Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.

Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 

When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 
Surgical treatment of pseudoaneurysm of the thoracic aorta

Surgical treatment of pseudoaneurysm of the thoracic aorta
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,
Aortic root remodeling leads to good valve stability in acute aortic dissection and preexistent root dilatation  Takashi Kunihara, MD, PhD, Niklas Neumann,

Aortic root remodeling leads to good valve stability in acute aortic dissection and preexistent root dilatation  Takashi Kunihara, MD, PhD, Niklas Neumann,
Bartosz Rylski, MD, Friedhelm Beyersdorf, MD, PhD, Fabian A

Bartosz Rylski, MD, Friedhelm Beyersdorf, MD, PhD, Fabian A
Surgery for acute type A aortic dissection on oral anticoagulants: Being the dispatcher of a 911 call  Ourania Preventza, MD, Arthur Bracey, MD  The Journal.

Surgery for acute type A aortic dissection on oral anticoagulants: Being the dispatcher of a 911 call  Ourania Preventza, MD, Arthur Bracey, MD  The Journal.
Supracoronary ascending aortic replacement in patients with acute aortic dissection type A: What happens to the aortic root in the long run?  Bartosz.

Supracoronary ascending aortic replacement in patients with acute aortic dissection type A: What happens to the aortic root in the long run?  Bartosz.

Similar presentations

Ads by Google